Finals- Scotts Flashcards
- Histamine can be found in different compartments in the
human body, and are released in varying conditions. Which of
the following is INCORRECT with regards to histamine?
A. Histamine can be released by allergens and physico-chemical
insults
B. Histamine has not been linked with neurotransmission in the
brain
C. Enterochromaffin-like cells in the stomach release histamine
to activate mucosa cells
D. Histamine is found in high concentrations at sites of potential
injury
Answer: B
Endogenous histamine functions as brain neurotransmitter.
[Autacoids: Anti-histamines and Anti-leukotrienes Trans]
- The triple response of Lewis classically describes the effect if
intradermal injection of histamine. Which of the following is not
consistent with the triple response?
A. Localized red spot
B. Swelling or production of edema
C. Bright red halo
D. Patchy orange induration
Answer: D
Triple response of Lewis includes: (1) localized red spot or
“flush” (2) swelling or edema or “wheal” and (3) brighter red
halo or “flare”. Choice D is not included. [Autacoids: Anti-
histamines and Anti-leukotrienes Trans]
- Which of the following is INCORRECT with regards to the pharmacodynamics effect of anti-histamine? A. Decrease extrapyramidal signs for acute dystonia associated with antipsychotics
B. Sedative effect is associated with second generation H1 blockers
C. Urinary retention and blurring of vision may be seen with ethanolamine use
D. Cetirizine inhibits mast cell release of histamine and some other mediators of inflammation
Answer: B
Sedative effect is common in 1st generation H1 blockers. Newer or 2nd generation H1 blockers such as loratadine are non-
sedating. [Autacoids: Anti-histamines and Anti-leukotrienes Trans]
- Immunologic processes account for the most important pathophysiologic mechanism of histamine release. Which of the following is TRUE with regards to the storage and release of histamine?
A. Involves neutrophil histamine release
B. Cells sensitized by IgE antibodies attached to their surface membranes
C. Histamine is also a mediator in Type-II hypersensitivity reactions
D. Histamine decreases chemotaxis of monocytes and lymphocytes
Answer: B
The most important pathophysiologic mechanism of mast cell and basophilhistamine release is immunologic. These cells, if sensitized by IgE antibodies attached to their membranes, degranulate when exposed to the appropriate antigen.
- Which of the following is FALSE with regards to the leukotrienes?
A. Leukotrienes are products of arachidonic acid metabolism through 5-Lipoxygenase pathway
B. Synthesized by airway inflammatory cells
C. Cys-Leukotrienes dominate during allergic constriction of the airway
D. Leukotrienes are only involved with increase airway mucosal secretion
- Which of the following is FALSE with regards to the leukotrienes?
A. Leukotrienes are products of arachidonic acid metabolism through 5-Lipoxygenase pathway
B. Synthesized by airway inflammatory cells
C. Cys-Leukotrienes dominate during allergic constriction of the airway
D. Leukotrienes are only involved with increase airway mucosal secretion
Answer: D
Choices A, B and C are true. Other functions of leukotrienes include bronchoconstriction, neutrophil chemoaattractant and mucosal edema.[Autacoids: Anti-histamines and Anti-leukotrienes Trans]
- The leukotriene which has the highest potency as a chemotactic agent for neutrophils
A. Leukotriene B4
B. Leukotriene C4
C. Leukotriene D4
D. Leukotriene E4
Answer: A
LTB4 – potent neutrophil chemoattractant
LTC4 and LTD4 (also LTE4) – bronchoconstriction, bronchial
reactivity, mucosal edema, mucosal hypersecretion [Autacoids:
Anti-histamines and Anti-leukotrienes Trans]
- Leukotriene pathway inhibitors are clinically effective for asthma. Which of the following is FALSE with regards to the effects of leukotrienes in asthma?
A. The anti-inflammatory effects may be less than
corticosteroids but nearly equal in reducing the frequency of exacerbations
B. Shown to reduce the asthmatic response to aspirin
C. Taken per orem
D. Zileuton is approved for children 6 years and above
Answer: D
Choices A, B and C are true. Zileuton causes occasional liver toxicity thus is least prescribed. MONTELUKAST is approved for children 6 years and above. [Autacoids: Anti-histamines and Anti-leukotrienes Trans]
- Which of the following is FALSE with regards to the
pharmacodynamics effects of leukotrienes?
A. Hypotension
B. Chemotaxis
C. Gastric acid production
D. Mucosal edema
Answer: C
LTC4 and LTD4 cause hypotension in humans (Brink, 2003). Mucosal edema is one of the functions of LTC4 and LTD4 (see explanation on number
6). LTB4 is a potent chemotactic agent.
LTs act principally on bronchial mucosa, not on gastric mucosa.
[Autacoids: Anti-histamines and Anti-leukotrienes Trans]
- Which of the following drugs / agents would reduce release of mediators from mast cells and basophils and produce brochodilation?
A. Prednisone
B. Isoproterenol
C. Montelukast
D. Antihistamines
Answer: D
H1 blockers (anti-histamines) involves inhibition of mast cells and basophil histamine release and some other mediators of inflammation. [Autacoids: Anti-histamines and Anti-leukotrienes Trans]
- Which of the following routes would probably be the best method to give epinephrine to a patient with anaphylactic shock?
A. Subcutaneous
B. Intramuscular
C. Intravenous
D. Sublingual
Answer: C
Management of patient in anaphylactic shock: Epinephrine IV (1:100,000) = 0.01mg/kg [Autacoids: Anti-histamines and Anti-leukotrienes Trans]
- Which of the following regarding the use of adrenergic agents in allergic rhinitis is true?
A. Use with caution in patients with hypertension.
B. Topical decongestants are less prone to abuse.
C. Oral decongestants are more prone to produce rebound congestion.
D. They can be safely taken by patients who are on MAO inhibitors.
Answer: A
A is correct. Phenylpropanolamine has already been withdrawn
for increased cardiac events in the US. B is wrong since topical
decongestants are more prone to abuse. C is also wrong since
oral decongestants decrease rebound congestion. D is also
wrong since adrenergic agents have an addictive effect with MAO inhibitors.
- Which of the following adrenergic agents exerts direct action on the alpha 2 adrenergic receptors?
a. phenylephrine
b. pseudoephedrine
c. oxymetazoline
d. epinephrine
Answer: C. Oxymetazoline
Oxymetazoline / Xyclometazoline exerrt clonidine like effects
and stimulate alpha 2 adrenergic receptors and promote constriction of nasal arterioles.
- Which of the following agents used topically for nasal decongestion would more likely cause mucosal damage?
A. epinephrine
B. phenylephrine
C. ephedrine
D. xylometazoline
Answer: A. Epinephrine
B, C, and D are all used as topical decongestants. Chronic use of A can cause structural damage of the mucosa.
- Which of the following decongestants releases stored catecholamines, has some direct effects on receptors, has good oral bioavailability and causes significant CNS stimulation?
A. Phenylephrine
B. Ephedrine
C. Oxymetazoline
D. Pseudoephedrine
Answer: B. Ephedrine
Ephedrine can be taken orally (does not resist oxidation by MAO), has direct action on receptors, MOA – releases stored catecholamines, and compared to pseudoephedrine- causes more CNS stimulation.
- True or False? The standard diluent for epinephrine is D5W.
Answer: False
A solution of 5%dextrosein water, sometimes called D5W, is often used instead if the patient is at risk for having lowblood sugar or highsodium. D5W is especially used in mixing and infusing medications due to its hypotonic properties –
Wikipedia. I read in a journal that epinephrine is diluted in endotracheal or endobronchial administration to increase its effectiveness, the usual diluents of epinephrine are normal saline (NS) and distilled water and according to the authors of the journal distilled water is a better diluents.
the journal distilled water is a better diluents.
- True or False? Bicarbonates are compatible with
epinephrine.
Answer: False
Epinephrine is incompatible withaminophilline, sodium bicarbonate or other alkaline solutions (Trans on Adrenergic Agents in Allergy p.2).
- True or False? Bicarbonates are compatible with epinephrine.
Answer: False
Epinephrine is incompatible withaminophilline, sodium bicarbonate or other alkaline solutions (Trans on Adrenergic Agents in Allergy p.2).
- The following are considered to be glucocorticoids:
A. Testosterone
B. Aldosterone
C. Cortisol
D. Dehydroepiandosterone
Answer: C.Testosterone
Testosterone, Aldosterone, Dehydroepiandosterone are all
mineralocorticoids.
- The following glucocorticoid has the highest mineralocorticoid potency:
A. dexamethasone
B. prednisone
C. betamethasone
D. hydroxycortisone
Answer: D. hydrocortisone
Cortisone and hydrocortisone have the highest mineralocorticoid potency with 2. Prednisone and prednisolone have 1. The rest have none.
19.A patient with allergic rhinitis was assessed to require steroids. This drug should be given
A. Systemically by intravenous route
B. By intramuscular route
C. By oral route (e.g. prednisone)
D. Inhaled/intranasal
Answer: D. Inhaled / intranasal
Intranasal corticosteroids are the first line of treatment for moderate to severe persistent rhinitis.
- The following are expected effects of steroids except:
A. Decrease calcium absorption in the gut
B. Increase glucose uptake by muscles
C. Blocks the synthesis of prostaglandins and leukotrienes
D. Protein catabolism
Answer: B. Increase glucose uptake by muscles
Steroids function by increasing glucose levels in the bloodstream during times of stress, thus there is decreased glucose uptake by muscles.
- The following practice decreases the likelihood of adverse effects with the use of glucocorticoids:
A. Give a higher dose at night than in the morning.
B. For contact dermatitis, steroids should be administered
systematically for faster absorption.
C. Use at the highest doses for optimal effect.
D. Give prednisone rather than dexamethasone whenever
possible.
Answer: D
Use short acting and/or topical drugs whenever possible to
minimize adverse effects. (prednisone has shorter half life than dexamethasone). Higher dose should be given in the morning otherwise ACTH will be suppressed if given at night. Use the lowest dose possible.
- The following adverse effect of glucocorticoids is attributed to its interaction and activation of the mineralocorticoid receptor:
A. Hyperglycemia or high blood sugar
B. Osteoporosis
C. Early bruising and thinning of the skin
D. Hypertension
Answer: D
Mineralocorticoid receptor activation produces sodium and water retention, eventually leading to hypertension.
- The following are normal physiologic processes concerning steroid secretion which we attempt to mimic whenever exogenous steroids are given:
A. The peak of ACTH secretion is early in the morning at around 8 am
B. The peak of cortisol secretion is at 8 pm
C. Mineralocorticoid secretion peaks at 8 am.
D. Cortisol secretion is lowest at around midnight.
Answer: D
ACTH peaks at midnight. Cortisol peaks early in the morning and is lowest at midnight. Mineralocorticoids have no peak.
- The only mineralocorticoid that has pharmacologic use:
A. Hydrocortisone
B. Prednisone
C. Fludrocortisone
D. Dexamethasone
Answer: C
A, B, and D are all glucocorticoids. Only C is a mineralocorticoid.
- Which of the following is the mechanism of action of
octreotide for the treatment of GH-secreting tumors?
a. competitive inhibition for the growth hormone (GH)
receptor
b. dopaminergic agonist inhibiting GH secretion
c. somatostatin-like effect inhibiting the release of GH
d. competes for the OGF-1 receptor
Answer: C. somatostatin-like effect inhibiting the release of GH
Explanation: Octreotide acetate is an eight-amino-acid synthetic somatostatin analogue. Somatostatin analogues
exert their therapeutic effects through SSTR2 and -5 receptors, both of which are invariably expressed by GH-secreting tumors. In contrast to native somatostatin, the analogue is relatively resistant to plasma degradation. It has a 2-h serum half-life and possesses fortyfold greater potency than native somatostatin to suppress or inhibit GH
release. (Harrison’s)
- All of the following drugs/chemical are inhibitors of prolactin secretion EXCEPT:
a. dopamine
b. bromocriptine
c. carbegoline
d. pegvisomant
Answer: D. pegvisomant
Explanation: Pegvisomant is a GH receptor antagonist.
Dopamine inhibits prolactin secretion while Bromocriptine and Cabergoline are ergot alkaloids used to treat hyperprolactinemia. (Harrison’s)
- All of the following are correct therapeutic targets in the treatment of prolactinomas EXCEPT:
a. resumption of regular monthly menses
b. pregnancy
c. shrinkage of the pituitary tumor
d. weight loss
Answer: D. weight loss
Explanation: Treatment of prolactinoma will address the amenorrhea and infertility associated with the said disorder.
- The following conditions will be amenable to growth
hormone injections EXCEPT:
a. Short stature due to Turner’s syndrome
b. Growth hormone deficiency in an 11 year old child
developing after surgery of craniopharyngioma in the sellar
area
c. Dwarfism due to congenital hypothyroidism
d. Growth restriction of a 13 year old due to chronic kidney disease
Answer: C. Dwarfism due to congenital hypothyroidism
Explanation: Growth hormone injections can be used to treat
growth failure in pediatric patient with GH deficiency, chronic renal failure, Noonan’s syndrome, Prader-Willi syndrome, Turner syndrome, small for gestational age with failure to catch up by age 2, and idiopathic short stature
- Gold standard or first line treatment of acromegaly:
a. Bromocriptine
b. Surgery (TSE)
c. Pegvisomant
d. Octreotide
Answer: B. surgery (TSE)
Explanation: The 1st line treatment for acromegaly is transphenoidal surgery. 2nd line is the use of somatostatin analogs. 3rd line is the use of dopamine agonist. The last resort will be radiation therapy.
- The following drugs can potentially decrease the cortisol
levels in Cushing’s syndrome EXCEPT:
a. Ketoconazole
b. Metyrapone
c. Octreotide
d. Aminogluthetimide
Answer: C. Octreotide
Explanation: Octreotide is a somatostatin analog used in the treatment of acromegaly.
- True about the management of patients with Type 1 diabetes mellitus:
a. the best treatment is insulin given once a day as a basal regimen in order to improve compliance.
b. the best treatment is combination of insulin given in a basal and prandial regimen
c. Type 1 diabetics using inhaled insulin will not require any more subcutaneous injection
d. Chronic or long term use is given as intramuscular injections
B
- The oral antidiabetic agent that is most notorious for hypoglycemia
a. Glimepiride
b. Metformin
c. Thiazolidinedione
d. Glibenclamide
e. Repaglinide
D
- The following drugs can be given specifically to control
postprandial blood sugar in Type 2 DM EXCEPT
a. Insulin aspart
b. Megletinides/glinides
c. alpha-glucosidase inhibitors
d. Insulin lispro
e. NPH insulin
E
- The following drugs can be given specifically to control postprandial blood sugar in Type 2 DM EXCEPT
a. Insulin aspart
b. Megletinides/glinides
c. alpha-glucosidase inhibitors
d. Insulin lispro
e. NPH insulin
A
- The most potent in terms of the amoung of lowering of both the FBS and HbA1c among the following oral agents:
a. Megletinides
b. Thiazolidinediones
c. Alpha glucosidase inhibitors
d. Sulfonylureas
D
- The most feared side effect of metformin use
a. bone marrow toxicity
b. hepatotoxicity
c. acute interstitial nephritis
d. lactic acidosis
e. hypoglycemia
D
- The mechanism of action of the following drugs involve a
glucose independent increase in insulin secretion EXCEPT for:
a. first generation sulfonylureas
b. megletinides
c. GLP-1
d. second generation sulfonylureas
C
- Your patient was injected with a mixture of two kinds of
insulin before breaskfast at 7am and was apparently well until
this referral. As the intern on duty, he is being referred to you
now at 930 am for cold sweats, blank stares and tremulousness.
You suspect hypoglycemia. The insulin that caused the
hypoglycemia is most probably:
a. insulin glargine
b. regular insulin
c. insulin detemir
d. NPH insulin
e. Lente insulin
no answer given
- Bolus insulin injected through this route has the shortest
halflife or is eliminated most quickly
a. intramuscular
b. subcutaneous
c. intravenous
d. intradermal
NAG
- This oral agent is approved for use by children with Type 2
diabetes:
a. metformin
b. sulfonylureas
c. alpha glucosidase inhibitors
d. thiazolidinediones
e. DPP-4 inhibitors
A
98: This drug is contraindicated among diabetic patients with
acute infection and sepsis
a. Regular insulin
b. NPH insulin
c. Megletinides
d. Metformin
D
- A patient is consulting you in the OPD for second opinion. He
was recently diagnosed to be diabetic and was given two
different drugs. Two weeks after starting these medications, he
developed bipedal edema. Unfortunately, he did not bring both
his prescription and the actual tablets, and just described his
medications as one large round tablet and one triangular tablet.
Which of the following oral anti-diabetic agents probably caused
the edema?
a. Metformin
b. Sulfonylurea
c. Thiazolidinedione
d. alpha glucosidase inhibitor
e. megletinide
C
- The drug of choice for a newly diagnosed overweight Type
2 diabetic with mild to moderate hyperglycemia
a. alpha glucosidase inhibitor
b. metformin
c. thiazolidinedione
d. megletinide
e. sulfonylurea
NAG
- The drug of choice for Type 2 diabetic patients with renal
failure:
a. alpha glucosidase inhibitor
b. metformin
c. insulin
d. sulfonylurea
e. GLP-1
NAG